/Companies

Lytica Therapeutics

Cambridge, US · Founded 2019 · Delaware corporation

Find your way into Lytica Therapeutics

Sign up to see every warm intro you have to Lytica Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Lytica Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

RM
RIDA MOURTADANamed on SEC filing

Board

JL
JAMES LATORREBoard director
DM
DANIEL MACAYABoard director
JD
JEAN-FRANCOIS DUCRESTBoard director

Reported raises · per SEC filings

Form D private placements

$11.8M disclosed across 3 rounds · 2024–2025

▶$6MraisedApr 2025 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JEAN-FRANCOIS DUCRESTDirector
  • JAMES LATORREDirector
  • DANIEL MACAYADirector
  • RIDA MOURTADAExecutive Officer, Director
Amount sold
$6M
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedAug 2024 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES LATORREDirector
  • DANIEL MACAYADirector
  • RIDA MOURTADAExecutive Officer, Director
  • JEAN-FRANCOIS DUCRESTDirector
Amount sold
$1.8M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.1MraisedMar 2024 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JEAN-FRANCOIS DUCRESTDirector
  • DANIEL MACAYADirector
  • RIDA MOURTADAExecutive Officer, Director
  • JAMES LATORREExecutive Officer, Director
Amount sold
$4.1M
First sale
Feb 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Lytica Therapeutics raised?
Lytica Therapeutics has disclosed $11.8M raised across 3 rounds.
Where is Lytica Therapeutics headquartered?
Lytica Therapeutics is headquartered in Cambridge, US.